Switch theme
Sign up to access all valuation multiples
AOTI Inc produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers globally. The company provides efficacious topical wound oxygen solutions for use in both the institutional and the home care setting to improve the health, well-being, and independence of patients. Its products include TWO2 Extremity Chamber, TWO2 Multi-Patch.
2008
n/a
LTM Revenue $48.1M
LTM EBITDA $7.8M
$108M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
AOTI has a last 12-month revenue of $48.1M and a last 12-month EBITDA of $7.8M.
In the most recent fiscal year, AOTI achieved revenue of $56.6M and an EBITDA of -$5.5M.
AOTI expects next 12-month revenue of XXX and NTM EBITDA of XXX
See AOTI valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $56.6M | $56.7M | XXX | XXX | XXX |
| Gross Profit | $26.8M | $38.0M | XXX | XXX | XXX |
| Gross Margin | 47% | 67% | XXX | XXX | XXX |
| EBITDA | -$5.5M | $8.7M | XXX | XXX | XXX |
| EBITDA Margin | -10% | 15% | XXX | XXX | XXX |
| Net Profit | $2.6M | -$3.6M | XXX | XXX | XXX |
| Net Margin | 5% | -6% | XXX | XXX | XXX |
| Net Debt | n/a | $10.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, AOTI's stock price is GBP 1 (or $1).
AOTI has current market cap of GBP 87.7M (or $113M), and EV of GBP 84.0M (or $108M).
See AOTI trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $108M | $113M | XXX | XXX | XXX | XXX | $0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, AOTI has market cap of $113M and EV of $108M.
AOTI's trades at 1.7x LTM EV/Revenue multiple, and 10.8x LTM EBITDA.
Analysts estimate AOTI's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for AOTI and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $108M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 12.4x | XXX | XXX | XXX |
| P/E | -64.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -138.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAOTI's NTM/LTM revenue growth is 31%
AOTI's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, AOTI's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate AOTI's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for AOTI and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -258% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 46% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 98% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AOTI acquired XXX companies to date.
Last acquisition by AOTI was XXXXXXXX, XXXXX XXXXX XXXXXX . AOTI acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was AOTI founded? | AOTI was founded in 2008. |
| Where is AOTI headquartered? | AOTI is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| Who is the CEO of AOTI? | AOTI's CEO is Dr. Michael Stephen Griffiths. |
| Is AOTI publicy listed? | Yes, AOTI is a public company listed on LON. |
| What is the stock symbol of AOTI? | AOTI trades under AOTI ticker. |
| When did AOTI go public? | AOTI went public in 2024. |
| Who are competitors of AOTI? | Similar companies to AOTI include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of AOTI? | AOTI's current market cap is $113M |
| What is the current revenue of AOTI? | AOTI's last 12-month revenue is $48.1M. |
| What is the current EBITDA of AOTI? | AOTI's last 12-month EBITDA is $7.8M. |
| What is the current EV/Revenue multiple of AOTI? | Current revenue multiple of AOTI is 1.7x. |
| What is the current EV/EBITDA multiple of AOTI? | Current EBITDA multiple of AOTI is 10.8x. |
| What is the current revenue growth of AOTI? | AOTI revenue growth between 2023 and 2024 was 0%. |
| Is AOTI profitable? | Yes, AOTI is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
